Birdwatch Note Rating
2024-03-16 00:00:04 UTC - HELPFUL
Rated by Participant: C0CC6665022A1A75B98A17B60DD9E8A7ABA8E93A6F3A6E645D314AF76F89BEB4
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 53% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://www.nejm.org/doi/full/10.1056/nejmoa1910993 https://www.paho.org/en/topics/ebola-virus-disease
All Note Details